Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

Transdifferentiation of fibroblasts to urothelial progenitors for definitive urothelial replacement therapy in non-muscle invasive bladder cancer

Funder: Bladder Cancer Advocacy Network

Funding period
USD 300 K
Funding amount
Abstract
Intermediate or high-risk non-muscle invasive bladder cancer that is refractory to Bacillus Calmette-Guérin has limited treatment options. Intravesical chemotherapy has limited efficacy, and radical cystectomy with urinary diversion, though effective in terms of recurrence-free survival, has a high rate of complications. As an alternative to radical cystectomy with urinary diversion in patients with recurrent non-muscle invasive bladder cancer, we propose to replace the bladder urothelium. The basis of this proposal centers upon our work in understanding how in the mouse, a lesion similar to human carcinoma in situ (CIS) develops from exposure to a carcinogenic agent and extensively proliferates to involve most, if not all, of the urothelium, necessitating complete urothelial replacement to avoid cancer recurrence and progression. In order to replace the urothelium, we must develop methods to generate bladder urothelial progenitor cells, and we propose to do this through transdifferentiation of fibroblasts. We will also develop methods to exfoliate the urothelium and transplant these cells, as well as measure the extent of the premalignant lesion. We hypothesize that replacement of the urothelium with urothelial progenitor cells from transdifferentiation will definitively prevent progression and recurrence of non-muscle invasive bladder cancer.
Similar projects All >
Sorted by: Start Date
Project list item
Developing a SMART scaffold for bladder augmentation

National Institute of Biomedical Imaging and Bioengineering to GUILLERMO ANTONIO AMEER, JOHN ROGERS, ARUN SHARMA

USD 709,004
2019 - 2023
Project list item
Role of Fgfr2 signaling in bladder injury and regeneration

National Institute of Diabetes and Digestive and Kidney Diseases to CARLTON MATTHEW BATES

USD 234,750
2019 - 2022
Project list item
[Chemoradiotherapy with MMC and UFT for muscle-invasive bladder cancer in elderly patients] - Original in Japanese

Japan Society for the Promotion of Science to Hisanori ARIGA, 光洋 菊池

USD 35,923
2019 - 2024
Project list item
[Development of cancer immunotherapy for urothelial carcinoma targeting tissue infiltrating regulatory T cells] - Original in Japanese

Japan Society for the Promotion of Science to Atsunari Kawashima, 尚 和田, Norio NONOMURA

USD 39,526
2019 - 2022

System

Categories
  • FOR (ANZSRC)

    1112 Oncology and Carcinogenesis

  • RCDC

    Stem Cell Research

  • RCDC

    Cancer

  • RCDC

    Stem Cell Research - Nonembryonic - Non-Human

  • RCDC

    Urologic Diseases

  • HRCS HC

    Cancer

  • Health Research Areas

    Biomedical

  • Broad Research Areas

    Clinical Medicine and Science